TriSalus jumps 16% after FDA clears TriNav Advance device
RegulatoryapprovedTriNav AdvancePositive
AI Analysis
Summary
TriSalus received FDA clearance for its TriNav Advance device, resulting in a 16% stock price increase. The approval represents a significant regulatory milestone for the company's device product.
Outcome Details
FDA cleared TriNav Advance device
Importance:8/10
Sentiment:
0.85
FDA approvalmedical deviceclearancestock movement
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on September 23, 2026 9:46 AM